The role of insulin receptors and IGF-I receptors in cancer and other diseases(1622 views) Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R
Archives Of Physiology And Biochemistry (ISSN: 1381-3455), 2008 Feb; 114(1): 23-37.
Keywords: Hybrid, Igf-I, Insulin Receptor Isoform, Tumour Progression, Isoprotein, Somatomedin, Somatomedin C Receptor, Human, Metabolism, Neoplasm, Review, Signal Transduction, Protein Isoforms, Igf Type 1, Animalia,
Affiliations: *** IBB - CNR ***
Department of Internal Medicine, Endocrinology Unit, University of Catania, PO Garibaldi Nesima, Via Palermo 636, 95122 Catania, Italy
Department of Clinical and Experimental Medicine, University of Catanzaro, Campus Loc. Germaneto, v.le Europa, 88100 Catanzaro, Italy
References: Adami, H.O., McLaughlin, J., Ekbom, A., Berne, C., Silverman, D., Hacker, D., Persson, I., (1991) Cancer Causes Control, 2, pp. 307-31
Andersen, A.S., Wiberg, F.C., Kjeldsen, T., (1995) Ann NY Acad Sci, 766, pp. 466-468
Finch, C.E., Ruvkun, G., (2001) Annu Rev Genomics Hum Genet, 2, pp. 435-462
Folsom, A.R., Kaye, S.A., Prineas, R.J., Potter, J.D., Gapstur, S.M., Wallace, R.B., (1990) Am J Epidemiol, 131, pp. 794-803
Foti, D., Iuliano, R., Chiefari, E., Brunetti, A., (2003) Mol Cell Biol, 23, pp. 2720-2732
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I.D., Vigneri, R., (1999) Mol Cell Biol, 19, pp. 3278-3288
Frasca, F., Rustighi, A., Malaguarnera, R., Altamura, S., Vigneri, P., Del Sal, G., Giancotti, V., Manfioletti, G., (2006) Cancer Res, 66, pp. 2980-2989
Frittitta, L., Vigneri, R., Papa, V., Goldfine, I.D., Grasso, G., Trischitta, V., (1993) Breast Cancer Res Treat, 25, pp. 73-82
Frittitta, L., Sciacca, L., Catalfamo, R., Ippolito, A., Gangemi, P., Pezzino, V., Filetti, S., Vigneri, R., (1999) Cancer, 85, pp. 492-498
Furlanetto, R.W., Dey, B.R., Lopaczynski, W., Nissley, S.P., (1997) Biochem J, 327 (PART 3), pp. 765-771
Giddings, S.J., Carnaghi, L.R., (1992) Mol Endocrinol, 6, pp. 1665-1672
Giorgino, F., Belfiore, A., Milazzo, G., Costantino, A., Maddux, B., Whittaker, J., Goldfine, I.D., Vigneri, R., (1991) Mol Endocrinol, 5, pp. 452-459
Giovannucci, E., (2001) J Nutr, 131, pp. 3109S-3120S
Gustavsson, J., Parpal, S., Karlsson, M., Ramsing, C., Thorn, H., Borg, M., Lindroth, M., Stralfors, P., (1999) Faseb J, 13, pp. 1961-1971
Hafen, E., (2004) Swiss Med Wkly, 134, pp. 711-719
Hansen, T., Bjorbaek, C., Vestergaard, H., Gronskov, K., Bak, J.F., Pedersen, O., (1993) J Clin Endocrinol Metab, 77, pp. 1500-1505
Pandini, G., Vigneri, R., Costantino, A., Frasca, F., Ippolito, A., Fujita-Yamaguchi, Y., Siddle, K., Belfiore, A., (1999) Clin Cancer Res, 5, pp. 1935-1944
Pandini, G., Wurch, T., Akla, B., Corvaia, N., Belfiore, A., Goetsch, L., (2007) Eur J Cancer, 43, pp. 1318-1327
Pandini, G., Frasca, F., Mineo, R., Sciacca, L., Vigneri, R., Belfiore, A., (2002) J Biol Chem, 277, pp. 39684-39695
Pandini, G., Conte, E., Medico, E., Sciacca, L., Vigneri, R., Belfiore, A., (2004) Ann N Y Acad Sci, 1028, pp. 450-456
Papa, V., Pezzino, V., Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G.B., Vigneri, R., (1990) J Clin Invest, 86, pp. 1503-1510
Papa, V., Gliozzo, B., Clark, G.M., McGuire, W.L., Moore, D., Fujita-Yamaguchi, Y., Vigneri, R., Pezzino, V., (1993) Cancer Res, 53, pp. 3736-3740
Yip, C.C., Hsu, H., Patel, R.G., Hawley, D.M., Maddux, B.A., Goldfine, I.D., (1988) Biochem Biophys Res Commun, 157, pp. 321-329
Yip, C.C., (1992) J Cell Biochem, 48, pp. 19-25
Yu, H., Rohan, T., (2000) J Natl Cancer Inst, 92, pp. 1472-1489
Zeigerer, A., McBrayer, M.K., McGraw, T.E., (2004) Mol Biol Cell, 15, pp. 4406-4415
Zerbe, L.K., Pino, I., Pio, R., Cosper, P.F., Dwyer-Nield, L.D., Meyer, A.M., Port, J.D., Malkinson, A.M., (2004) Mol Carcinog, 41, pp. 187-196
Adami, H. O., McLaughlin, J., Ekbom, A., Berne, C., Silverman, D., Hacker, D., Persson, I., (1991) Cancer Causes Control, 2, pp. 307-31
Andersen, A. S., Wiberg, F. C., Kjeldsen, T., (1995) Ann NY Acad Sci, 766, pp. 466-468
Baumann, C. A., Ribon, V., Kanzaki, M., Thurmond, D. C., Mora, S., Shigematsu, S., Bickel, P. E., Saltiel, A. R., (2000) Nature, 407, pp. 202-207
Benoliel, A. M., Kahn-Perles, B., Imbert, J., Verrando, P., (1997) J Cell Sci, 110 (PART 17), pp. 2089-2097
Blakesley, V. A., Stannard, B. S., Kalebic, T., Helman, L. J., LeRoith, D., (1997) J Endocrinol, 152, pp. 339-344
Bowker, S. L., Majumdar, S. R., Veugelers, P., Johnson, J. A., (2006) Diabetes Care, 29, pp. 254-258
Bray, G. A., (2002) J Nutr, 132, pp. 3451S-3455S
Bruning, P. F., Bonfrer, J. M., van Noord, P. A., Hart, A. A., de Jong-Bakker, M., Nooijen, W. J., (1992) Int J Cancer, 52, pp. 511-516
Burgering, B. M., Kops, G. J., (2002) Trends Biochem Sci, 27, pp. 352-360
Caceres, J. F., Stamm, S., Helfman, D. M., Krainer, A. R., (1994) Science, 265, pp. 1706-1709
Calle, E. E., Thun, M. J., (2004) Oncogene, 23, pp. 6365-6378
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., Thun, M. J., (2003) N Engl J Med, 348, pp. 1625-1638
Calle, E. E., Kaaks, R., (2004) Nat Rev Cancer, 4, pp. 579-591
Catrina, S. B., Lewitt, M., Massambu, C., Dricu, A., Grunler, J., Axelson, M., Biberfeld, P., Brismar, K., (2005) Br J Cancer, 92, pp. 1467-1474
Ceresa, B. P., Pessin, J. E., (1998) Mol Cell Biochem, 182, pp. 23-29
Chiang, S. H., Baumann, C. A., Kanzaki, M., Thurmond, D. C., Watson, R. T., Neudauer, C. L., Macara, I. G., Saltiel, A. R., (2001) Nature, 410, pp. 944-948
Cohen, N. D., Hilf, R., (1974) Cancer Res, 34, pp. 3245-3252
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., Thun, M. J., (2004) Am J Epidemiol, 159, pp. 1160-1167
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., Greenberg, M. E., (1997) Cell, 91, pp. 231-241
Evans, J. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., Morris, A. D., (2005) BMJ, 330, pp. 1304-1305
Finch, C. E., Ruvkun, G., (2001) Annu Rev Genomics Hum Genet, 2, pp. 435-462
Folsom, A. R., Kaye, S. A., Prineas, R. J., Potter, J. D., Gapstur, S. M., Wallace, R. B., (1990) Am J Epidemiol, 131, pp. 794-803
Furlanetto, R. W., Dey, B. R., Lopaczynski, W., Nissley, S. P., (1997) Biochem J, 327 (PART 3), pp. 765-771
Giddings, S. J., Carnaghi, L. R., (1992) Mol Endocrinol, 6, pp. 1665-1672
Harrington, L. S., Findlay, G. M., Lamb, R. F., (2005) Trends Biochem Sci, 30, pp. 35-42
Heuson, J. C., Legros, N., Heimann, R., (1972) Cancer Res, 32, pp. 233-238
Ho, T. H., Charlet, B. N., Poulos, M. G., Singh, G., Swanson, M. S., Cooper, T. A., (2004) Embo J, 23, pp. 3103-3112
Ho, T. H., Savkur, R. S., Poulos, M. G., Mancini, M. A., Swanson, M. S., Cooper, T. A., (2005) J Cell Sci, 118, pp. 2923-2933
Kalli, K. R., Falowo, O. I., Bale, L. K., Zschunke, M. A., Roche, P. C., Conover, C. A., (2002) Endocrinology, 143, pp. 3259-3267
Khandwala, H. M., McCutcheon, I. E., Flyvbjerg, A., Friend, K. E., (2000) Endocr Rev, 21, pp. 215-244
Knowlden, J. M., Hutcheson, I. R., Barrow, D., Gee, J. M., Nicholson, R. I., (2005) Endocrinology, 146, pp. 4609-4618
Kops, G. J., de Ruiter, N. D., De Vries-Smits, A. M., Powell, D. R., Bos, J. L., Burgering, B. M., (1999) Nature, 398, pp. 630-634
Kozma, S. C., Thomas, G., (2002) Bioessays, 24, pp. 65-71
Ladd, A. N., Nguyen, N. H., Malhotra, K., Cooper, T. A., (2004) J Biol Chem, 279, pp. 17756-17764
Laviola, L. G., Chow, J. C., Baquero, J. A., Hansen, H., Ooi, J., Zhu, J., Riedel, H. S. R., (1997) J Clin Invest, 99, pp. 830-837
Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., Efstratiadis, A., (1993) Cell, 75, pp. 59-72
Liu, F., Roth, R. A., (1998) Mol Cell Biochem, 182, pp. 73-78
Mastick, C. C., Kato, H., Roberts Jr, C. T., LeRoith, D., Saltiel, A. R., (1994) Endocrinology, 135, pp. 214-222
Mathieu, M. C., Clark, G. M., Allred, D. C., Goldfine, I. D., Vigneri, R., (1997) Proc Assoc Am Physicians, 109, pp. 565-571
McClain, D. A., (1991) Mol Endocrinol, 5, pp. 734-739
Moller, D. E., Yokota, A., Caro, J. F., Flier, J. S., (1989) Mol Endocrinol, 3, pp. 1263-1269
Mountjoy, K. G., Finlay, G. J., Holdaway, I. M., (1987) Cancer Res, 47, pp. 6500-6504
Mynarcik, D. C., Williams, P. F., Schaffer, L., Yu, G. Q., Whittaker, J., (1997) J Biol Chem, 272, pp. 18650-18655
Osborne, C. K., Monaco, M. E., Lippman, M. E., Kahn, C. R., (1978) Cancer Res, 38, pp. 94-102
Ottensmeyer, F. P., Beniac, D. R., Luo, R. Z., Yip, C. C., (2000) Biochemistry, 39, pp. 12103-12112
Patel, N. A., Chalfant, C. E., Watson, J. E., Wyatt, J. R., Dean, N. M., Eichler, D. C., Cooper, D. R., (2001) J Biol Chem, 276, pp. 22648-22654
Patel, N. A., Apostolatos, H. S., Mebert, K., Chalfant, C. E., Watson, J. E., Pillay, T. S., Sparks, J., Cooper, D. R., (2004) Mol Endocrinol, 18, pp. 899-911
Patel, N. A., Kaneko, S., Apostolatos, H. S., Bae, S. S., Watson, J. E., Davidowitz, K., Chappell, D. S., Cooper, D. R., (2005) J Biol Chem, 280, pp. 14302-14309
Pierantoni, G. M., Rinaldo, C., Esposito, F., Mottolese, M., Soddu, S., Fusco, A., (2006) Cell Death Differ, 13, pp. 1554-1563
Pillay, T. S., Sasaoka, T., Olefsky, J. M., (1995) J Biol Chem, 270, pp. 991-994
Pollak, M. N., Schernhammer, E. S., Hankinson, S. E., (2004) Nat Rev Cancer, 4, pp. 505-518
Sarbassov, D. D., Guertin, D. A., Ali, S. M., Sabatini, D. M., (2005) Science, 307, pp. 1098-1101
Saudek, C. D., (1997) Endocrinol Metab Clin North Am, 26, pp. 599-610
Savkur, R. S., Philips, A. V., Cooper, T. A., (2001) Nat Genet, 29, pp. 40-47
Schapira, D. V., (1991) J Am Med Womens Assoc, 46, pp. 126-130
Shymko, R. M., Dumont, E., De Meyts, P., Dumont, J. E., (1999) Biochem J, 339 (PART 3), pp. 675-683
Soos, M. A., Nave, B. T., Siddle, K., (1993) Adv Exp Med Biol, 343, pp. 145-157
Soos, M. A., Whittaker, J., Lammers, R., Ullrich, A., Siddle, K., (1990) Biochem J, 270, pp. 383-390
Tazzari, P. L., Tabellini, G., Bortul, R., Papa, V., Evangelisti, C., Grafone, T., Martinelli, G., Martelli, A. M., (2007) Leukemia, 21, pp. 886-896
Wang, H. S., Wang, T. H., (2003) Chang Gung Med J, 26, pp. 540-553
Webster, N. J., Evans, L. G., Caples, M., Erker, L., Chew, S. L., (2004) BMC Mol Biol, 5, p. 7
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J. M., Previs, S., Zhang, Y., White, M. F., (1998) Nature, 391, pp. 900-904
Yip, C. C., Hsu, H., Patel, R. G., Hawley, D. M., Maddux, B. A., Goldfine, I. D., (1988) Biochem Biophys Res Commun, 157, pp. 321-329
Yip, C. C., (1992) J Cell Biochem, 48, pp. 19-25
Zerbe, L. K., Pino, I., Pio, R., Cosper, P. F., Dwyer-Nield, L. D., Meyer, A. M., Port, J. D., Malkinson, A. M., (2004) Mol Carcinog, 41, pp. 187-196
The role of insulin receptors and IGF-I receptors in cancer and other diseases
There is evidence, both in vitro and in vivo, that receptor tyrosine kinases play a key role in the formation and progression of human cancer. In particular, the insulin-like growth factor receptor (IGF-IR), a tyrosine kinase receptor for IGF-I and IGF-II, has been well documented in cell culture, animal studies, and humans to play a role in malignant transformation, progression, protection from apoptosis, and metastasis.In addition, the hormone insulin (which is very closely related to the IGFs) and its tyrosine kinase receptor (the IR, which is very closely related to the IGR-IR) have been documented both in vitro and in vivo to play a key role in cancer biology. Indeed, several epidemiological studies have shown that insulin resistance status, characterized by hyperinsulinaemia, is associated with an increased risk for a number of malignancies, including carcinomas of the breast, prostate, colon and kidney.Recent data have elucidated some molecular mechanisms by which IR is involved in cancer. IR is over-expressed in several human malignancies. Interestingly, one of die two IR isoform (IR-A) is especially over-expressed in cancer. IR-A is the IR foetal isoform and has the peculiar characteristic to bind not only insulin but also IGF-II.In addition, the IR contributes to formation of hybrid receptors with the IGF-IR (HR). By binding to hybrid receptors, insulin may stimulate specific IGF-IR signalling pathways. Over-expression of IR-A is, therefore, a major mechanism of IGF system over-activation in cancer. In this respect, IR-A isoform and hybrid receptors should be regarded as potential molecular targets, in addition to IGF-IR, for novel anti-cancer therapy.These findings may have important implications for both the prevention and treatment of common human malignancies. They underline the concept that hyperinsulinaemia, associated with insulin resistance and obesity, should be treated by changes in life style and/or pharmacological approaches to avoid an increased risk for cancer. Moreover, native insulin and insulin analogue administration should be carefully evaluated in terms of the possible increase in cancer risk.
The role of insulin receptors and IGF-I receptors in cancer and other diseases
No results.
The role of insulin receptors and IGF-I receptors in cancer and other diseases